Evidence for autosomal dominant inheritance of prostate cancer
- PMID: 9585590
- PMCID: PMC1377141
- DOI: 10.1086/301862
Evidence for autosomal dominant inheritance of prostate cancer
Abstract
A family-history cancer survey was conducted on 5,486 men who underwent a radical prostatectomy, for clinically localized prostate cancer, in the Department of Urology at the Mayo Clinic during 1966-95; 4,288 men responded to the survey. Complex segregation analysis was performed to assess the genetic basis of age at diagnosis and the familial clustering of prostate cancer. For the total group, no single-gene model of inheritance clearly explained familial clustering of disease, which could be partly explained by lack of Hardy-Weinberg equilibrium, with an excess of homozygotes. After accounting for deviations from Hardy-Weinberg equilibrium, the best-fitting model that explained the familial aggregation and age at diagnosis was a rare autosomal dominant susceptibility gene, and this model fitted best when probands were diagnosed at <60 years of age. The model predicts that the frequency of the susceptibility gene in the population is .006 and that the risk of prostate cancer by age 85 years is 89% among carriers of the gene and 3% among noncarriers. A strength of our study is its large size, such that genetic models could be fitted within strata defined by the age of the proband. Although the autosomal dominant model was consistently the best model, the parameter estimates differed somewhat (P=.03) across the different age groups, suggesting genetic heterogeneity. Additional evidence that the hereditary basis of prostate cancer is likely to be genetically complex was provided by the following: (1) there was a significantly elevated age-adjusted risk of prostate cancer among brothers of probands, compared with their fathers (relative risk 1.5 [95% confidence interval 1.4-1.7]); (2) the autosomal dominant model predicted an excess of homozygotes, over that predicted by Hardy-Weinberg equilibrium; and (3) the model-predicted risk of prostate cancer among relatives was inadequate when probands were diagnosed at age >=70 years.
Similar articles
-
Autosomal dominant inheritance of prostate cancer: a confirmatory study.Urology. 2001 Jan;57(1):97-101. doi: 10.1016/s0090-4295(00)00891-8. Urology. 2001. PMID: 11164151
-
Segregation analysis of prostate cancer in France: evidence for autosomal dominant inheritance and residual brother-brother dependence.Ann Hum Genet. 2003 Mar;67(Pt 2):125-37. doi: 10.1046/j.1469-1809.2003.00022.x. Ann Hum Genet. 2003. PMID: 12675688
-
Mendelian inheritance of familial prostate cancer.Proc Natl Acad Sci U S A. 1992 Apr 15;89(8):3367-71. doi: 10.1073/pnas.89.8.3367. Proc Natl Acad Sci U S A. 1992. PMID: 1565627 Free PMC article.
-
Familial risk factors for prostate cancer.Cancer Surv. 1991;11:5-13. Cancer Surv. 1991. PMID: 1841757 Review.
-
[Heredity in renal and prostatic neoplasia].Arch Ital Urol Androl. 1997 Sep;69(4):241-6. Arch Ital Urol Androl. 1997. PMID: 9417296 Review. Italian.
Cited by
-
New insights and candidate genes and their implications for care of patients with hereditary prostate cancer.Curr Urol Rep. 2000 May;1(1):9-14. doi: 10.1007/s11934-000-0029-x. Curr Urol Rep. 2000. PMID: 12084335 Review.
-
Combined analysis of hereditary prostate cancer linkage to 1q24-25: results from 772 hereditary prostate cancer families from the International Consortium for Prostate Cancer Genetics.Am J Hum Genet. 2000 Mar;66(3):945-57. doi: 10.1086/302807. Am J Hum Genet. 2000. PMID: 10712209 Free PMC article.
-
Segregation analyses of 1,476 population-based Australian families affected by prostate cancer.Am J Hum Genet. 2001 May;68(5):1207-18. doi: 10.1086/320114. Epub 2001 Apr 11. Am J Hum Genet. 2001. PMID: 11309686 Free PMC article.
-
Comparison of microsatellites versus single-nucleotide polymorphisms in a genome linkage screen for prostate cancer-susceptibility Loci.Am J Hum Genet. 2004 Dec;75(6):948-65. doi: 10.1086/425870. Epub 2004 Oct 8. Am J Hum Genet. 2004. PMID: 15514889 Free PMC article.
-
Prostate cancer: a comprehensive review.Med Oncol. 2000 May;17(2):85-105. doi: 10.1007/BF02796203. Med Oncol. 2000. PMID: 10871814 Review. No abstract available.
References
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical